<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04927962</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/20/0255</org_study_id>
    <nct_id>NCT04927962</nct_id>
  </id_info>
  <brief_title>Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta</brief_title>
  <acronym>AiDiBull</acronym>
  <official_title>Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta in Young People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to study the impact of dentinogenesis (DI) and amelogenesis&#xD;
      (AI) imperfecta on oral quality of life, exposure to bullying and dental anxiety in a&#xD;
      population of adolescents. We will use validated scales to evaluate the impact of bullying on&#xD;
      the oral quality of live of youth aged 10 to 18 years, with non-syndromic DI or AI treated in&#xD;
      seven national competence or reference centers in rare oral diseases.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Child Oral Health Impact Profile (COHIP)</measure>
    <time_frame>Baseline</time_frame>
    <description>Difference between the average total COHIP questionnaire score of bullied and non bullied patients at D0 (no follow up is planned). A youth is considered bullied if he or she answers &quot;three or more&quot; at least once on the Bullying and Cyberbullying scale for Adolescent questionnaire)</description>
  </primary_outcome>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Dentinogenesis Imperfecta</condition>
  <condition>Amelogenesis Imperfecta</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>For youth: self-reported questionnaires (on oral quality of life, bullying and cyberbullying, dental anxiety) and routine clinical examination for adolescents. For one parent: self-reported questionnaires (on perceived oral quality of life of their child and on their own dental anxiety).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having a non-syndromic amelogenesis imperfecta or dentinogenesis imperfecta and&#xD;
        consulting in the O-Rare CRMRs of Strasbourg and Paris-Rothschild or the CCMRs of Bordeaux,&#xD;
        Lyon, Marseille, Nantes, Toulouse for a care or follow-up consultation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  be between 10 and 18 years of age,&#xD;
&#xD;
          -  consult in the O-Rare CRMRs of Strasbourg and Paris-Rothschild or the CCMRs of&#xD;
             Bordeaux, Lyon, Marseille, Nantes, Toulouse for a care or follow-up consultation&#xD;
&#xD;
          -  having a non-syndromic amelogenesis imperfecta or dentinogenesis imperfecta&#xD;
&#xD;
          -  having access to a cell phone and/or tablet and/or personal or family computer&#xD;
&#xD;
          -  covered by the social security of one of his parents&#xD;
&#xD;
          -  understand French and one of whose parents (or legal representative) understands&#xD;
             French&#xD;
&#xD;
          -  have declared his or her non-opposition and one of whose parents (or legal&#xD;
             representative) has declared his or her non-opposition to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Child presenting for diagnostic consultation and child who cannot read or whose 2&#xD;
             parents (legal representatives) cannot read&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuelle Noirrit-Esclassan</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emmanuelle Noirrit-Esclassan</last_name>
    <phone>0561778378</phone>
    <email>noirrit.e@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alice Broutin</last_name>
    <email>broutin.a@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University hospital of Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Emmanuelle Noirrit-Esclassan</last_name>
      <email>noirrit.e@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alice Broutin</last_name>
      <email>broutin.a@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Alice BROUTIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2021</study_first_posted>
  <last_update_submitted>June 9, 2021</last_update_submitted>
  <last_update_submitted_qc>June 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amelogenesis imperfecta</keyword>
  <keyword>Dentinogenesis imperfecta</keyword>
  <keyword>Bullying</keyword>
  <keyword>Oral health related quality of life</keyword>
  <keyword>Dental anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amelogenesis Imperfecta</mesh_term>
    <mesh_term>Dentinogenesis Imperfecta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

